Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema

Authors:
  • FNfor the Diabetic Retinopathy Clinical Research Network
    for the Diabetic Retinopathy Clinical Research Network
Top Cited Papers
Open Access
Publisher website
Google Scholar
Abstract
Studies have demonstrated the benefit of intravitreous anti–vascular endothelial growth factor (VEGF) injections for improving visual acuity and decreasing retinal thickening in eyes with diabetic macular edema (DME).1-4 Nevertheless, in 32% to 66% of eyes treated with at least 6 monthly injections, edema persisted, often with reduced visual acuity.2 Thus, there is a need for additional treatments for eyes with suboptimal response to anti-VEGF therapy.

This publication has 21 references indexed in Scilit: